Industries > Pharma > Blood Screening Market Report 2019-2029

Blood Screening Market Report 2019-2029

By Technology (NAT, ELISA, CLIA, NGS, Western Blotting) and by Product (Reagents, Instruments) Segments

PAGES: 152
PRODUCT CODE: PHA0514
SUBMARKET: Digital Healthcare

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1
SKU: PHA0514 Categories: , Tags: ,

A blood screening is a therapeutic procedure which allows blood to be analysed for a particular illness or condition. In this process, blood is mostly tried for HIV1, HIV2, HBV, HCV, jungle fever, syphilis, and different irresistible ailments. It is mostly done to reduce the chances of transfusion-transmitted contaminations (TTIs).

Market Overview and Trends
The growth of the blood screening market is due to rise in the screening of donor and technological advancement in this sector. Demand for blood screening tests has been on the rise in recent years thanks to the surge in donation, boosted awareness about transfusion-transmitted diseases, and technological advancements among others. Moreover, governments across the nations are striving to mandate testing of all the donated blood for a number of viruses.

Factors Influencing the Market Growth:
• The ever increasing demand for donated blood and the donors.
• The increased number of blood donation camps.
• Higher awareness among users regarding safety and knowledge of donated blood.
• Economic price and acceptance of NAT for blood screening

Factors Restraining the Market Growth:
• Lack of proper regulations in developing countries for the use of NAT
• Lack of finance required for capital investments and high maintenance cost of NAT, especially in emerging markets
• Evolution of substitute technologies

Market Segmentation 2019-2029:
The blood screening market is segmented on the technologies, product & service types, geography.

Technologies Covered:
• Nucleic Acid Amplification Test (NAT)
• Transcription-Mediated Amplification (TMA)
• Real-Time Polymerase Chain Reaction (PCR)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• ELISA Market, By Platform
• ELISA Market, By Generation
• Rapid Tests
• Next-Generation Sequencing (NGS)
• Western Blotting

Product & Service Types Covered:
• Reagent and Kits Market, 2019-2029
• NAT Reagents & Kits Market, 2019-2029
• ELISA Reagents & Kits Market, 2019-2029
• Enzymes and Polymerases Market, 2019-2029
• Standards And Controls Market, 2019-2029
• Probes And Primers Market, 2019-2029
• Buffers, Nucleotides, And Solutions Market, 2019-2029
• Immunosorbents Market, 2019-2029
• Controls Market, 2019-2029
• Instruments Market, 2019-2029
• Rental Purchase Market, 2019-2029
• Outright Purchase Market, 2019-2029
• Software and Services Market, 2019-2029

Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Blood Screening market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
Grifols, F. Hoffmann-La Roche, Abbott Laboratories, Biomérieux, Bio-Rad Laboratories, Inc., Siemens Healthineers (A Subsidiary Of Siemens AG), Ortho Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc., Beckman Coulter (A Subsidiary Of Danaher Corporation), Becton, Dickinson And Company

Key questions answered by this report:
• What is the current size of the total global blood Screening market?
• How much will this market be worth from 2018 to 2029?
• How is the blood Screening market evolving?
• What is driving and restraining the blood Screening market?
• What are the market shares of each segment of the overall blood Screening market currently and how will these change to 2029?
• What are the main submarkets and how much revenue will each blood Screening market submarket account for over the next 10 years to 2029 and why?
• How will the market shares for each blood Screening market submarket develop from 2018 to 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve to 2029?
• What are the largest national markets for blood Screening market? What is the current status and how will it develop over the next ten years? What are their forecasts for 2019-2029?
• Who are the most prominent companies, and what are their activities and outlooks?
• What are the main trends that will affect the blood Screening market between 2018 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the blood Screening market. You find data, trends and predictions.

Buy our report today Blood Screening Market 2019-2029: By Technology (NAT, ELISA, CLIA, NGS, Western Blotting) & By Product (Reagents, Instruments) Segments.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Blood Screening Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Blood Screening Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Categories